Brief: VBL Therapeutics Reports Full Year 2021 Financial Results
23/03/2022 11:13
March 23 (Reuters) - Vascular Biogenics Ltd VBLT.O :
* VBL THERAPEUTICS REPORTS FULL YEAR 2021 FINANCIAL RESULTS
AND
PROVIDES CORPORATE UPDATE
* VBL THERAPEUTICS - EXPECTS CASH, CASH EQUIVALENTS
SUFFICIENT TO
FUND PLANNED OPERATING EXPENSES AND CAPITAL EXPENDITURES FOR AT
LEAST TWELVE MONTHS
Source text for Eikon: ID:nGNX6yM5q0
Further company coverage: VBLT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Notable Labs
See all newsUS STOCKS-Wall St ends sharply lower following Trump's anti-Powell tirade
US STOCKS-Wall St ends sharply lower amid Trump's tirade against Fed's Powell
US STOCKS-Wall St tumbles as Trump ramps up tirade against Fed's Powell
Brief: Notable Labs Says Co, Units Filed Voluntary Petition Under Provisions Of Chapter 7 Of Title 11 Of US Bankruptcy Code
Brief: Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives